| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910557626103321 |
|
|
Autore |
Stuart James M |
|
|
Titolo |
Bacterial Meningitis : Epidemiology and Vaccination |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (274 p.) |
|
|
|
|
|
|
Soggetti |
|
Biology, life sciences |
Research & information: general |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
This timely collection of expert papers draws attention to the global burden of meningitis and the challenges faced by the WHO's roadmap to defeat meningitis by 2030. The three main goals of the meningitis roadmap are to eliminate epidemics of bacterial meningitis, reduce cases and deaths from vaccine-preventable bacterial meningitis, and reduce disability and improve quality of life after meningitis of any cause. This book includes a wide range of original research and reviews on epidemiology and vaccination of bacterial meningitis that have direct relevance to advancing the goals of the roadmap. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910346689303321 |
|
|
Autore |
Marianecci Carlotta |
|
|
Titolo |
Smart Nanovesicles for Drug Targeting and Delivery / Carlotta Marianecci, Maria Carafa |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
|
Basel, Switzerland : , : MDPI, , 2019 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 electronic resource (198 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Nanovesicles are highly-promising systems for the delivery and/or targeting of drugs, biomolecules and contrast agents. Despite the fact that initial studies in this area were performed on phospholipid vesicles, there is an ever-increasing interest in the use of other molecules to obtain smart vesicular carriers focusing on strategies for targeted delivery. These systems can be obtained using newly synthesized smart molecules, or by intelligent design of opportune carriers to achieve specific delivery to the site of action. The drug/contrast agent-containing vesicles need to be directed to precise locations within the body to obtain desired magnitude and duration of the therapeutic or diagnostic effect. This spatial control in the delivery might open new avenues to modulate drug activity while avoiding side-effects and to optimize contrast agent properties while avoiding a broad distribution in the organism. However, delivering and targeting active substances into specific tissues and cells is still a challenge in designing novel therapeutic approaches against untreatable disorders, such as tumors and degenerative diseases. |
|
|
|
|
|
|
|
| |